Tag: Osteoporosis
USPSTF Recommends Osteoporosis Screening for Women 65 Years and Older
Screening to prevent osteoporotic fractures also recommended for postmenopausal women younger than 65 years at increased risk; evidence lacking for screening men
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage
Risk increased with worsening CKD stage with denosumab versus bisphosphonates; highest risk seen for dialysis-dependent CKD, CKD-mineral and bone disorder
Severe Mental Illness Tied to Fragility Fractures in People 50 Years and Older
For people aged 50 years and older with severe mental illness, risk for fragility fractures is increased across all ages
USPSTF Recommends Osteoporosis Screening for Women Aged 65 Years and Older
Screening also recommended for postmenopausal women aged younger than 65 years with one or more risk factors
Osteoporosis Screening Rates Low for Asian American Medicare Beneficiaries
Among Asian American beneficiaries, rates higher for women, those with higher household income
People With Acute Calcium Pyrophosphate Face Doubled Risk for Fracture
Findings seen for first fracture at the humerus, wrist, hip, or pelvis
Residential Greenness Tied to Increased Bone Density, Lower Osteoporosis Risk
Risk for osteoporosis lower for those exposed to high normalized difference vegetation index and low genetic risk
Denosumab Linked to Severe Hypocalcemia in Dialysis-Dependent Seniors
Risk increased for severe and very severe hypocalcemia for female dialysis-dependent Medicare patients aged 65 years or older
Common Tools Suboptimal for ID’ing Fracture Risk in Younger Postmenopausal Women
Findings seen for the Fracture Risk Assessment Tool and the Osteoporosis Self-Assessment Tool
